Frontal lobe proton magnetic-resonance spectroscopy in Graves' disease: a pilot study. (Q48359805)

11 February 2018

title

Frontal lobe proton magnetic-resonance spectroscopy in Graves' disease: a pilot study. (English)

1 reference

11 February 2018

1 reference

Bhatara VS

1

1 reference

11 February 2018

Tripathi RP

2

1 reference

11 February 2018

Sankar R

3

1 reference

11 February 2018

Gupta A

4

1 reference

11 February 2018

Khushu S

5

1 reference

11 February 2018

publication date

1 August 1998

1 reference

11 February 2018

published in

Psychoneuroendocrinology

1 reference

11 February 2018

volume

23

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

605-612

1 reference

11 February 2018

Choline and cholinergic neurons

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Cerebral blood flow evidence of right frontal activation in attention demanding tasks.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Dissociation in prefrontal cortex of affective and attentional shifts

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Thyroid hormones as neurotransmitters

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Emotional disturbance and cognitive deficits in hyperthyroidism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Perils and pitfalls on the path to normal potential: the role of impaired attention. Homage to Herbert G. Birch

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Brain metabolism in hypothyroidism studied with 31P magnetic-resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

A survey study of neuropsychiatric complaints in patients with Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

A multidisciplinary approach to anterior attentional functions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Psychiatric and neuropsychological response to propranolol in Graves' disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Cerebral volumes and spectroscopic proton metabolites on MR: is sex important?

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Choline metabolism as a basis for the selective vulnerability of cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Mental changes accompanying thyroid gland dysfunction. A reappraisal using objective psychological measurement.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

Acute hyperthyroidism: cognitive and emotional correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0306-4530%2898%2900028-6

7 January 2021

10.1016/S0306-4530(98)00028-6

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

9802130

1 reference

11 February 2018